Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hilliard L Kutscher

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Antimicrobial Agents and Chemotherapy|April 20, 2026
Weekly pulmonary delivery of β-glucan-chitosan-poly(lactic co-glycolic) acid (β-C-P) nanoparticles with daily standard oral therapy achieves control of <i>Mycobacterium tuberculosis</i> in BALB/c miceHilliard L Kutscher, Maria Tamblin, Patrick Kenney, et al.
Immunological Investigations|October 24, 2017
Volatile Anesthetics and ImmunitySiavash Sedghi, Hilliard L Kutscher, Bruce A Davidson, et al.
Journal of Medicinal Chemistry|January 13, 2010
A series of alpha-amino acid ester prodrugs of camptothecin: in vitro hydrolysis and A549 human lung carcinoma cell cytotoxicityManjeet Deshmukh, Piyun Chao, Hilliard L Kutscher, et al.
Pharmaceutical Research|February 3, 2019
In vitro Pharmacokinetic Cell Culture System that Simulates Physiologic Drug and Nanoparticle Exposure to MacrophagesHilliard L Kutscher, Gene D Morse, Paras N Prasad, et al.
Critical Reviews in Biomedical Engineering|January 3, 2021
Curcumin-Pluronic Nanoparticles: A Theranostic Nanoformulation for Alzheimer's DiseaseAjay Singh, Supriya D Mahajan, Hilliard L Kutscher, et al.
Journal of Visualized Experiments : Jove|March 14, 2017
Open Tracheostomy Gastric Acid Aspiration Murine Model of Acute Lung Injury Results in Maximal Acute Nonlethal Lung InjuryRavi Alluri, Hilliard L Kutscher, Barbara A Mullan, et al.
Antimicrobial Agents and Chemotherapy|January 14, 2026
Repeated pulmonary dosing of β-glucan-chitosan-PLGA nanoparticles controls <i>Mycobacterium tuberculosis</i> in miceHilliard L Kutscher, Maria Tamblin, Evon Smith, et al.
Journal of Drug Delivery|May 19, 2016
Poly(lactic-co-glycolic) Acid-Chitosan Dual Loaded Nanoparticles for Antiretroviral NanoformulationsFaithful Makita-Chingombe, Hilliard L Kutscher, Sara L DiTursi, et al.
Journal of Pharmaceutical Sciences|June 15, 2020
A Multimodal Theranostic Nanoformulation That Dramatically Enhances Docetaxel Efficacy Against Castration Resistant Prostate CancerJulia C Bulmahn, Hilliard L Kutscher, Katherine Cwiklinski, et al.
Frontiers in Bioengineering and Biotechnology|June 12, 2023
An immunoregulator nanomedicine approach for the treatment of tuberculosisLuona Yang, Lee Chaves, Hilliard L Kutscher, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Antimicrobial Agents and Chemotherapy|April 20, 2026
Weekly pulmonary delivery of β-glucan-chitosan-poly(lactic co-glycolic) acid (β-C-P) nanoparticles with daily standard oral therapy achieves control of <i>Mycobacterium tuberculosis</i> in BALB/c miceHilliard L Kutscher, Maria Tamblin, Patrick Kenney, et al.
Immunological Investigations|October 24, 2017
Volatile Anesthetics and ImmunitySiavash Sedghi, Hilliard L Kutscher, Bruce A Davidson, et al.
Journal of Medicinal Chemistry|January 13, 2010
A series of alpha-amino acid ester prodrugs of camptothecin: in vitro hydrolysis and A549 human lung carcinoma cell cytotoxicityManjeet Deshmukh, Piyun Chao, Hilliard L Kutscher, et al.
Pharmaceutical Research|February 3, 2019
In vitro Pharmacokinetic Cell Culture System that Simulates Physiologic Drug and Nanoparticle Exposure to MacrophagesHilliard L Kutscher, Gene D Morse, Paras N Prasad, et al.
Critical Reviews in Biomedical Engineering|January 3, 2021
Curcumin-Pluronic Nanoparticles: A Theranostic Nanoformulation for Alzheimer's DiseaseAjay Singh, Supriya D Mahajan, Hilliard L Kutscher, et al.
Journal of Visualized Experiments : Jove|March 14, 2017
Open Tracheostomy Gastric Acid Aspiration Murine Model of Acute Lung Injury Results in Maximal Acute Nonlethal Lung InjuryRavi Alluri, Hilliard L Kutscher, Barbara A Mullan, et al.
Antimicrobial Agents and Chemotherapy|January 14, 2026
Repeated pulmonary dosing of β-glucan-chitosan-PLGA nanoparticles controls <i>Mycobacterium tuberculosis</i> in miceHilliard L Kutscher, Maria Tamblin, Evon Smith, et al.
Journal of Drug Delivery|May 19, 2016
Poly(lactic-co-glycolic) Acid-Chitosan Dual Loaded Nanoparticles for Antiretroviral NanoformulationsFaithful Makita-Chingombe, Hilliard L Kutscher, Sara L DiTursi, et al.
Journal of Pharmaceutical Sciences|June 15, 2020
A Multimodal Theranostic Nanoformulation That Dramatically Enhances Docetaxel Efficacy Against Castration Resistant Prostate CancerJulia C Bulmahn, Hilliard L Kutscher, Katherine Cwiklinski, et al.
Frontiers in Bioengineering and Biotechnology|June 12, 2023
An immunoregulator nanomedicine approach for the treatment of tuberculosisLuona Yang, Lee Chaves, Hilliard L Kutscher, et al.
Pageof 4